2. Academic Validation
  3. Deciphering the role of IGF2BP2 and PRMT5 in gallbladder cancer progression: insights from multi-omics analysis

Deciphering the role of IGF2BP2 and PRMT5 in gallbladder cancer progression: insights from multi-omics analysis

  • Br J Cancer. 2025 Jun 24. doi: 10.1038/s41416-025-03062-w.
Xinwei Yang # 1,  Lingqi Sun # 2,  Jiamin Guo 3,  Yichen Zheng 3,  Tonghui Ren 3,  Ying Liu 4,  Lingnan Zheng 3,  Ji Ma 5
Affiliations

Affiliations

  • 1 Department of Biliary Surgery IV, Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai, China.
  • 2 Sleep Medicine Center, Mental Health Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • 3 Division of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China.
  • 4 Department of Breast Surgery, The 940 Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou, PR China.
  • 5 Division of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China. majimrn@163.com.
  • # Contributed equally.
PMID: 40555776 DOI: 10.1038/s41416-025-03062-w
Abstract

Background: Gallbladder Cancer (GBC) is a highly aggressive malignancy with limited therapeutic options and a poor prognosis. Elucidating the molecular mechanisms driving GBC progression is essential for identifying novel therapeutic targets.

Methods: Single-cell transcriptomics, high-throughput Sequencing, and proteomics techniques were employed to investigate the role of the IGF2BP2-PRMT5 axis in GBC. Functional assays were conducted to assess cell proliferation, invasion, and migration, while mechanistic studies examined the impact of N6-methyladenosine (m6A) modifications and downstream signalling pathways. Furthermore, a humanised mouse model was utilised to examine the impact of this axis on immune cell infiltration and tumour immune evasion.

Results: IGF2BP2 was found to stabilise PRMT5 expression via m6A modifications, thereby promoting GBC cell proliferation, invasion, and migration. Mechanistically, PRMT5 activated the Akt/mTOR pathway, upregulated SREBP1, and reprogrammed lipid metabolism, leading to increased lipid synthesis and accumulation. Functional assays and in vivo experiments revealed that modulation of the IGF2BP2-PRMT5 axis significantly influenced immune cell infiltration, fostering immune evasion.

Conclusions: The IGF2BP2-PRMT5 axis is critical in GBC progression by orchestrating metabolic reprogramming and immune modulation. Targeting this axis holds potential as a therapeutic strategy for combating GBC.

Figures
Products